This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Kim Hei-Man Chow: Innovator in Cancer Treatment
Introduction
Kim Hei-Man Chow is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research. His work focuses on developing methods to inhibit histone deacetylase, which plays a crucial role in cancer progression.
Latest Patents
Chow holds a patent for "Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors." This patent outlines a method for treating cancer by inhibiting the activity of histone deacetylase. The method involves administering a composition containing a therapeutically effective amount of a gold(III) complex or a pharmaceutically acceptable salt thereof to a human in need of such treatment. He has 1 patent to his name.
Career Highlights
Chow is affiliated with The University of Hong Kong, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Chow collaborates with esteemed colleagues, including Chi Ming Che and Yu Wang, who contribute to his research endeavors.
Conclusion
Kim Hei-Man Chow is a pioneering inventor whose work in cancer treatment showcases the importance of innovation in medical research. His contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile